Valuation: Optiscan Imaging Limited

Market Cap 125M 88.12M 76.51M 71.34M 65.53M 124M 8.38B 841M 329M 4.19B 331M 324M 13.88B P/E 2024
-31.8x
P/E 2025 -14.5x
Enterprise Value 122M 85.96M 74.64M 69.59M 63.93M 121M 8.18B 820M 321M 4.09B 323M 316M 13.54B EV / Sales 2024
62.1x
EV / Sales 2025 23.8x
Free-Float
36.32%
Yield 2024 *
-
Yield 2025 -
1 day+6.90%
Current month+6.90%
1 month+14.81%
3 months+40.91%
6 months+72.22%
Current year+55.00%
1 week 0.14
Extreme 0.145
0.16
1 month 0.13
Extreme 0.13
0.16
Current year 0.08
Extreme 0.08
0.16
1 year 0.08
Extreme 0.079
0.16
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.29
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 2021-12-12
Director of Finance/CFO - 2025-03-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2021-02-09
Chairman - 2021-04-18
Director/Board Member - 2021-05-05
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Free

Director

230,502 0.0221%
1/15/26 Free

Chairman

419,094 0.0401%
1/15/26 Free

Chief Executive Officer

6,157,719 0.5897%
Change 5-day change 1-year change 3-year change Capi.($)
+6.90%0.00%+55.00%+96.20% 106M
-1.74%+3.59%-14.17%-16.24% 14.13B
+4.78%-4.83%+42.93%-4.91% 3.84B
+1.36%+10.99%-34.59%-52.83% 1.29B
+1.08%+14.19%-31.28%-38.64% 1.25B
+1.71%-2.05%+40.74%+93.22% 1.17B
+1.19%+5.08%-44.33% - 960M
+3.72%-6.82%+21.84%+94.41% 455M
-3.21%+4.99%+77.49% - 358M
-1.82%+0.53%-60.42%+229.27% 262M
Average +1.40%+2.54%+5.32%+50.06% 2.38B
Weighted average by Cap. +0.03%+1.43%-3.63%-6.33%

Financials

2024 2025
Net sales 2.99M 2.1M 1.82M 1.7M 1.56M 2.95M 200M 20.04M 7.84M 99.85M 7.89M 7.71M 331M 3.72M 2.62M 2.27M 2.12M 1.95M 3.68M 249M 25M 9.77M 125M 9.84M 9.62M 413M
Net income -6.06M -4.26M -3.7M -3.45M -3.17M -5.99M -405M -40.68M -15.9M -203M -16M -15.65M -671M -6.31M -4.44M -3.85M -3.59M -3.3M -6.24M -422M -42.37M -16.56M -211M -16.67M -16.3M -699M
Net Debt -11.01M -7.74M -6.72M -6.27M -5.76M -10.89M -737M -73.91M -28.89M -368M -29.08M -28.44M -1.22B -3.07M -2.16M -1.88M -1.75M -1.61M -3.04M -205M -20.61M -8.06M -103M -8.11M -7.93M -340M
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
26-08-04 A$0.1550 +6.90% 165,069
26-08-03 A$0.1450 0.00% 252,423
26-07-31 A$0.1450 -3.33% 172,716
26-07-30 A$0.1500 0.00% 23,762
26-07-29 A$0.1500 0.00% 95